VMD Stock Overview
Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VMD from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Viemed Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$10.45 |
| 52 Week High | CA$16.25 |
| 52 Week Low | CA$8.14 |
| Beta | 1.19 |
| 1 Month Change | -2.70% |
| 3 Month Change | 8.29% |
| 1 Year Change | 3.88% |
| 3 Year Change | 2.05% |
| 5 Year Change | 110.26% |
| Change since IPO | 335.42% |
Recent News & Updates
Recent updates
Is Viemed Healthcare (TSE:VMD) A Risky Investment?
Sep 13
The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence
May 27Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Feb 18Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Oct 27Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital
Jul 08Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?
Mar 10These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well
Dec 09Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why
Jun 04Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt
May 18Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?
Mar 03I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease
Feb 16Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly
Feb 03If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns
Jan 21
Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?
Jan 08Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?
Dec 22Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?
Nov 25Shareholder Returns
| VMD | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 4.6% | 0.7% | 1.2% |
| 1Y | 3.9% | 32.9% | 16.9% |
Return vs Industry: VMD underperformed the Canadian Healthcare industry which returned 7.6% over the past year.
Return vs Market: VMD matched the Canadian Market which returned 4.2% over the past year.
Price Volatility
| VMD volatility | |
|---|---|
| VMD Average Weekly Movement | 6.9% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: VMD has not had significant price volatility in the past 3 months.
Volatility Over Time: VMD's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 988 | Casey Hoyt | www.viemed.com |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices.
Viemed Healthcare, Inc. Fundamentals Summary
| VMD fundamental statistics | |
|---|---|
| Market cap | CA$311.76m |
| Earnings (TTM) | CA$12.20m |
| Revenue (TTM) | CA$225.10m |
33.0x
P/E Ratio1.8x
P/S RatioIs VMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VMD income statement (TTM) | |
|---|---|
| Revenue | US$169.78m |
| Cost of Revenue | US$66.21m |
| Gross Profit | US$103.57m |
| Other Expenses | US$94.36m |
| Earnings | US$9.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 61.00% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 9.1% |
How did VMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/23 03:39 |
| End of Day Share Price | 2023/12/21 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viemed Healthcare, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nick Corcoran | Acumen Capital Finance Partners Limited |
| Doug Cooper | Beacon Securities Limited |
| Vadim Merkulov | Freedom Broker |